AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Caprice Resources

0.091

+0.0022.25%

Volume:3.72M

Turnover:341.27K

Market Cap:79.30M

PE:-22.11

High:0.095

Open:0.089

Low:0.088

Close:0.089

52wk High:0.160

52wk Low:0.066

Shares:871.44M

Float Shares:644.73M

Volume Ratio:1.68

T/O Rate:0.58%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.004

EPS(LYR):-0.008

ROE:-12.20%

ROA:-7.58%

PB:3.15

PE(LYR):-11.70

Loading ...

Overview Company News Filings

Southern Copper Corp Stock (SCCO) Moved Up by 3.81% on Apr 10: Drivers Behind the Movement

Is It Too Late To Consider Carpenter Technology (CRS) After Its 136% One Year Surge

Simply Wall St.

Assessing Carpenter Technology (CRS) Valuation After Strong Multi‑Year Shareholder Returns

Simply Wall St.

Caprice Resources Starts Multi-Rig Drilling Campaign in Western Australia; Shares Down 14%

MT Newswires Live

Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs

A Look At Carpenter Technology (CRS) Valuation After A Strong Multi Year Share Price Run

Simply Wall St.

BUZZ-Australia's Caprice Resources slides on discounted placement

BRIEF-Caprice Resources To Raise A$12.74 Million Placement At A$0.08 Per Share

Caprice Resources - to Raise a$12.74 Mln Placement at a$0.08 per Share

THOMSON REUTERS

BRIEF-Caprice Resources Requests Trading Halt

Caprice Resources Ltd - Requests Trading Halt Pending Capital Raising Announcement

THOMSON REUTERS

Is Strong Q2 Beat And Higher Guidance Altering The Investment Case For Carpenter Technology (CRS)?

Simply Wall St.

Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases

XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication

Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)

The Bull Case For Carpenter Technology (CRS) Could Change Following CEO Succession To Brian Malloy - Learn Why

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/CRS.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CRS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CRS.AU\",,,,,undefined,":{"symbol":"CRS.AU","market":"AU","secType":"STK","nameCN":"Caprice Resources","latestPrice":0.091,"timestamp":1787292720000,"preClose":0.089,"halted":0,"volume":3722096,"delay":0,"changeRate":0.02247191011235957,"nameEN":"Caprice Resources","floatShares":644725953,"shares":871443814,"eps":-0.004115,"marketStatus":"Market Closed","change":0.002,"latestTime":"08-21 16:12:00 AEST","open":0.089,"high":0.095,"low":0.088,"amount":341267,"amplitude":0.078652,"askPrice":0.095,"askSize":250000,"bidPrice":0.09,"bidSize":324041,"shortable":3,"etf":0,"ttmEps":-0.004115,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.089,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":1.679057327127259,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CRS.AU","preClose":0.089,"auctionPrice":0.091,"auctionVolume":153538,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600775}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CRS.AU\",,,,,undefined,":{"symbol":"CRS.AU","floatShares":644725953,"roa":"-7.58%","roe":"-12.20%","lyrEps":-0.00778,"volumeRatio":1.679057327127259,"shares":871443814,"dividePrice":0,"high":0.095,"amplitude":0.078652,"preClose":0.089,"low":0.088,"week52Low":0.066,"pbRate":"3.15","psRate":"818.39","week52High":0.16,"institutionHeld":0,"latestPrice":0.091,"committee":0.128982,"eps":-0.004115,"divideRate":0,"volume":3722096,"delay":0,"ttmEps":-0.004115,"open":0.089,"prevYearClose":0.094,"prevWeekClose":0.09,"prevMonthClose":0.085,"prevQuarterClose":0.085,"fiveDayClose":0.09,"twentyDayClose":0.082,"sixtyDayClose":0.086,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRS.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-08-14","symbol":"CRS.AU","defaultRemindTime":1597363200000,"type":"split","dateTimestamp":1597327200000,"forFactor":2147483647,"toFactor":2147483647,"ratio":0.925577}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRS.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2626116387","title":"Southern Copper Corp Stock (SCCO) Moved Up by 3.81% on Apr 10: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626116387","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626116387?lang=en_us&edition=fundamental","pubTime":"2026-04-10 22:15","pubTimestamp":1775830519,"startTime":"0","endTime":"0","summary":"• Goldman Sachs upgraded Southern Copper to Neutral from Sell.\n• Analyst upgrade cites copper scarcity premium and strong company fundamentals.\n• JPMorgan projects refined copper deficit in 2026 due to high demand.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/Market-Movers/261771132-market-movers-scco-20260410","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRH","HGmain","CRS.AU","IE0031619046.USD","LU1093756168.USD","PICK","COPJ","QCmain","COPP","LU1506573853.SGD","LU2298321311.HKD","BK4011","ICOP","XME","CPER","CRS","LU0612318971.USD","LU0310800379.SGD","LU0132412106.USD","IE00B66KJ199.SGD","LU0788109121.HKD","FCXG","CPXR","LU0072463663.USD","DBB","LU0300736492.USD","BK4588","MHGmain","FCX","SCCO","COPX","SOJE","LU1992135472.HKD","SETM","LU0792757196.USD","LU1291149836.SGD","LU2360108059.USD","LU0612318385.USD","LU1267930813.SGD","IE00B19Z9P08.USD","SOJD","LU2463526074.USD","IE00B7SZLL34.SGD","IE00B7SZL793.SGD","LU0868494708.USD","IE00BFXG1179.USD","LU0171281750.USD","LU2092937221.SGD","LU0029864427.USD","LU0345780950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624269633","title":"Is It Too Late To Consider Carpenter Technology (CRS) After Its 136% One Year Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2624269633","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624269633?lang=en_us&edition=fundamental","pubTime":"2026-04-03 07:40","pubTimestamp":1775173203,"startTime":"0","endTime":"0","summary":"If you are wondering whether Carpenter Technology's share price still offers value after a strong run, the key is understanding what the current market price is actually baking in.\nThe stock closed at US$391.51, with returns of around flat over 7 days, a 2.4% decline over 30 days, a 15.7% gain year to date and a 135.9% gain over the last year, while the 3 year and 5 year returns are both very large.\nRecent attention on sector trends and company specific developments has kept Carpenter...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice1-main-header/1585186785008","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice1-main-header/1585186785008"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-crs/carpenter-technology/news/is-it-too-late-to-consider-carpenter-technology-crs-after-it-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-crs/carpenter-technology/news/is-it-too-late-to-consider-carpenter-technology-crs-after-it-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CRS","CRS.AU","BK4187","DCF","BK4006","IE00B7SZL793.SGD","LU2065731478.USD","IE0031619046.USD","BK7095","IE00B19Z4B17.USD","LU0963586101.USD","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621209503","title":"Assessing Carpenter Technology (CRS) Valuation After Strong Multi‑Year Shareholder Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2621209503","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621209503?lang=en_us&edition=fundamental","pubTime":"2026-03-24 22:12","pubTimestamp":1774361542,"startTime":"0","endTime":"0","summary":"Why Carpenter Technology is on investors’ radar\nCarpenter Technology (CRS) has drawn fresh attention after recent trading left the stock with a market value of about US$18.1b and a last close near US$373 per share.\nSee our latest analysis for Carpenter Technology.\nThe recent 1-day share price return of 2.98% to US$373.19 comes after a 30-day share price return of 4.24% and a year-to-date share price return of 10.30%, while the 1-year total shareholder return of 91.81% and very large 5-year...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice1-main-header/1585186785008","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice1-main-header/1585186785008"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-crs/carpenter-technology/news/assessing-carpenter-technology-crs-valuation-after-strong-mu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-crs/carpenter-technology/news/assessing-carpenter-technology-crs-valuation-after-strong-mu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4006","IE00B19Z4B17.USD","CRS.AU","BK7095","LU0963586101.USD","LU2065731478.USD","BK4187","IE00B7SZL793.SGD","IE0031619046.USD","CRS","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621728187","title":"Caprice Resources Starts Multi-Rig Drilling Campaign in Western Australia; Shares Down 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621728187","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621728187?lang=en_us&edition=fundamental","pubTime":"2026-03-23 09:35","pubTimestamp":1774229728,"startTime":"0","endTime":"0","summary":"Caprice Resources  started a multi-rig drilling campaign across its projects in the Murchison region of Western Australia covering roughly 50,000 meters, according to a Monday filing with the Australian bourse.The program is designed to target resource growth, high-grade extensions, and identify discoveries to inform an initial mineral resource estimate, the filing said.Shares fell 14% in midday trade on Monday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","BK4168","XAO.AU","XJO.AU","CRS.AU","WRN","XKO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620026984","title":"Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs","url":"https://stock-news.laohu8.com/highlight/detail?id=2620026984","media":"prnewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620026984?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:30","pubTimestamp":1773793800,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, March 18, 2026 /PRNewswire/ -- Antengene Corporation Limited  , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that it will present results from three preclinical studies in poster presentations at the 2026 American Association for Cancer Research Annual Meeting , taking place from April 17th to 22th, at the San Diego Convention Center, California, the United States. The presentations will feature ATG-125 , an IO + ADC dual-function molecule being developed for the treatment of solid tumors, as well as two investigational T cell engagers  developed using the company's proprietary AnTenGager TCE platform, including ATG-106  for ovarian and kidney cancers, and ATG-112  for gynecological tumors, digestive system malignancies, bladder cancers and NSCLC.AT","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-to-present-on-three-preclinical-programs-at-aacr-2026-highlighting-next-generation-adcs-and-antengager-tces-302716126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","CRS.AU","IND","CRS","BK4006","IE00B7SZL793.SGD","LU2065731478.USD","LU0963586101.USD","BK4145","BK7095","IND.AU","BK4187","IE00B66KJ199.SGD","ALPP","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619999438","title":"A Look At Carpenter Technology (CRS) Valuation After A Strong Multi Year Share Price Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2619999438","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619999438?lang=en_us&edition=fundamental","pubTime":"2026-03-16 10:13","pubTimestamp":1773627232,"startTime":"0","endTime":"0","summary":"Carpenter Technology (CRS) has attracted fresh attention after recent price moves, with the stock closing at US$361.28. For investors, the bigger question is how that price lines up with recent performance.\nSee our latest analysis for Carpenter Technology.\nThe recent pullback, including a 4.2% 1 day share price decline and 6.7% 7 day share price return, comes after a strong run that has left the 1 year total shareholder return at 97.6% and the 5 year total shareholder return above 8x.\nIf...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice1-main-header/1585186785008","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice1-main-header/1585186785008"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-crs/carpenter-technology/news/a-look-at-carpenter-technology-crs-valuation-after-a-strong","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-crs/carpenter-technology/news/a-look-at-carpenter-technology-crs-valuation-after-a-strong","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4006","IE00B19Z4B17.USD","BK4187","LU0963586101.USD","IE00B7SZL793.SGD","CRS.AU","USD.AU","USD","CRS","BK7095","IE0031619046.USD","IE00B66KJ199.SGD","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618160916","title":"BUZZ-Australia's Caprice Resources slides on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2618160916","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618160916?lang=en_us&edition=fundamental","pubTime":"2026-03-09 11:40","pubTimestamp":1773027607,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Caprice Resources slides on discounted placement** Shares of Caprice Resources CRS.AX fall as much as 14.7% to A$0.081, their largest intraday pct drop since early December 2025** Stock hits lowest since February 16, on track for third straight day of losses** Diversified miner receives firm commitments to raise A$12.74 million  via a private placement** Placement issue price at A$0.08 per share, a 15.8% discount to stock's last close** Says funds will be used to advance exploration at co's Murchison gold projects in Western Australia** More than 3.4 million shares change hands, 1.3 times the 30-day average** Stock down 12.8% YTD, including the day's moves  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL4N3ZX0BK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRS.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618697709","title":"BRIEF-Caprice Resources To Raise A$12.74 Million Placement At A$0.08 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2618697709","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618697709?lang=en_us&edition=fundamental","pubTime":"2026-03-09 09:04","pubTimestamp":1773018257,"startTime":"0","endTime":"0","summary":"BRIEF-Caprice Resources To Raise A$12.74 Million Placement At A$0.08 Per ShareMarch 9 (Reuters) - Caprice Resources Ltd CRS.AX:TO RAISE A$12.74 MILLION PLACEMENT AT A$0.08 PER SHAREFurther company coverage: CRS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZU1F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","CRS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618503694","title":"Caprice Resources  - to Raise a$12.74 Mln Placement at a$0.08 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2618503694","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618503694?lang=en_us&edition=fundamental","pubTime":"2026-03-09 07:02","pubTimestamp":1773010946,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260308:nFWN3ZU1F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","CRS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617572375","title":"BRIEF-Caprice Resources Requests Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2617572375","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617572375?lang=en_us&edition=fundamental","pubTime":"2026-03-06 06:51","pubTimestamp":1772751097,"startTime":"0","endTime":"0","summary":"BRIEF-Caprice Resources Requests Trading Halt March 6 (Reuters) - Caprice Resources Ltd CRS.AX:REQUESTS TRADING HALT PENDING CAPITAL RAISING ANNOUNCEMENTFurther company coverage: CRS.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT1HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","CRS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617572320","title":"Caprice Resources Ltd - Requests Trading Halt Pending Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2617572320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617572320?lang=en_us&edition=fundamental","pubTime":"2026-03-06 06:51","pubTimestamp":1772751069,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nFWN3ZT1HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","CRS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616559973","title":"Is Strong Q2 Beat And Higher Guidance Altering The Investment Case For Carpenter Technology (CRS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2616559973","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616559973?lang=en_us&edition=fundamental","pubTime":"2026-03-04 22:30","pubTimestamp":1772634610,"startTime":"0","endTime":"0","summary":"In its recently reported Q2 FY2026 results, Carpenter Technology posted earnings per share of $2.33 on revenue of $728 million, both ahead of expectations and fueled by strong aerospace demand and new long-term agreements. \nManagement also lifted full-year FY2026 operating income guidance by roughly one-third versus FY2025, a shift that has drawn supportive analyst commentary and highlighted growing confidence in the company’s earnings power. \nWe’ll now examine how Carpenter Technology’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice1-main-header/1585186785008","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice1-main-header/1585186785008"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-crs/carpenter-technology/news/is-strong-q2-beat-and-higher-guidance-altering-the-investmen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-crs/carpenter-technology/news/is-strong-q2-beat-and-higher-guidance-altering-the-investmen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0963586101.USD","CRS.AU","BK4585","BK4187","IE00B19Z4B17.USD","CRS","IE0031619046.USD","IE00B66KJ199.SGD","BK4588","LU2065731478.USD","BK4006","IE00B7SZL793.SGD","ITA","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616377532","title":"Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2616377532","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616377532?lang=en_us&edition=fundamental","pubTime":"2026-03-04 06:00","pubTimestamp":1772575200,"startTime":"0","endTime":"0","summary":"Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager  antibody, targeting B cell-related autoimmune diseases.Antengene will receive USD 80 million of upfront and near-term milestone payments, and is eligible to receive more than USD 1.1 billion in success-based development, regulatory and sales milestones, along with tiered royalties on future net sales.Deal underscores AnTenGager platform's unique capabilities in developing next-generation novel TCEs with broad applicability. Following this collaboration, 9 disclosed products remain in the R&D pipeline under the AnTenGager platform.Antengene to host conference call and webcast at 9:00 a.m. HKT  and 10:00 p.m. HKT  on Wednesday, March 4, 2026.Antengene's AnTenGager platform offers a differentiated T-cell engager ap","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-and-ucb-enter-global-license-agreement-for-atg-201-a-cd19cd3-bispecific-t-cell-engager-for-autoimmune-diseases-302702650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","IE0031619046.USD","IE00B66KJ199.SGD","IE00B7SZL793.SGD","LU0963586101.USD","USD","CRS.AU","LU2065731478.USD","BK7095","IE00B19Z4B17.USD","CRS","CD3.AU","BK4006","BK4187","UCB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616701288","title":"XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2616701288","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616701288?lang=en_us&edition=fundamental","pubTime":"2026-03-02 08:30","pubTimestamp":1772411400,"startTime":"0","endTime":"0","summary":"- XPOVIO is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service  for the treatment of adult patients with multiple myeloma .- In South Korea, XPOVIO has been approved for three indications across MM and diffuse large B-cell lymphoma , and two of these approved indications have been included in the national reimbursement scheme.SHANGHAI and HONG KONG, March 2, 2026 /PRNewswire/ -- Antengene Corporation Limited  , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that South Korea's National Health Insurance Service  has approved the reimbursement of XPOVIO  in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma  after one prior therapy. The reimbursement has taken effect on March 1, 2","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/xpovio-receives-reimbursement-approval-in-south-korea-for-a-second-multiple-myeloma-indication-302700204.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4187","IND.AU","CRS","LU2065731478.USD","IE00B66KJ199.SGD","BK4006","IE00B19Z4B17.USD","CRS.AU","LU0963586101.USD","IE0031619046.USD","IE00B7SZL793.SGD","IND","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614722974","title":"Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614722974","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614722974?lang=en_us&edition=fundamental","pubTime":"2026-02-25 08:30","pubTimestamp":1771979400,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, Feb. 25, 2026 /PRNewswire/ -- Antengene Corporation Limited  , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies, announced that it has entered into a clinical collaboration agreement with Shanghai Junshi Biosciences Co., Ltd . Under the collaboration, the parties will jointly evaluate the synergistic therapeutic potential of Antengene's ATG-037, an oral small-molecule CD73 inhibitor, in combination with Junshi Biosciences' JS207, a recombinant humanized anti-PD-1/VEGF bispecific antibody, in patients with solid tumors in Mainland China, with the goal of identifying clinical signals across multiple tumor types.","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-announces-clinical-collaboration-with-junshi-biosciences-to-explore-the-synergistic-potential-of-atg-037-oral-cd73-inhibitor-in-combination-with-js207-pd-1vegf-bsab-302695694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","BK4187","IE0031619046.USD","BK4023","HCC","ORR","LU0963586101.USD","IND.AU","IE00B66KJ199.SGD","BK4097","LU1169590202.USD","LU2065731478.USD","CRS","IE00B7SZL793.SGD","RCC","LU1169589451.USD","OS","CRS.AU","BK7095","IND","IE00B19Z4B17.USD","PD","ORR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613464733","title":"The Bull Case For Carpenter Technology (CRS) Could Change Following CEO Succession To Brian Malloy - Learn Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2613464733","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613464733?lang=en_us&edition=fundamental","pubTime":"2026-02-23 23:25","pubTimestamp":1771860346,"startTime":"0","endTime":"0","summary":"Carpenter Technology Corporation recently announced that CEO Tony R. Thene will step down on July 1, 2026, with current President and COO Brian Malloy taking over as President and CEO while Thene transitions to Executive Chairman on the same date.\nMalloy’s deep operational background across aerospace, defense, and energy end-markets positions him to steer Carpenter’s specialty alloys business as it pursues growth in these technically demanding applications.\nWe’ll now examine how this planned...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice1-main-header/1585186785008","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice1-main-header/1585186785008"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-crs/carpenter-technology/news/the-bull-case-for-carpenter-technology-crs-could-change-foll","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-crs/carpenter-technology/news/the-bull-case-for-carpenter-technology-crs-could-change-foll","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B19Z4B17.USD","IE0031619046.USD","CRS","BK4006","BK4187","CRS.AU","IE00B66KJ199.SGD","LU2065731478.USD","LU0963586101.USD","BK7095","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":36,"code":"91000000","status":"200"}]}}